Abstract

Guideline Objective
  1. To identify molecular tests that improve the classification of non-gastrointestinal stromal tumour (non-GIST) soft tissue sarcomas (STS)
  2. Identify genetic tests that are of prognostic significance in non-GIST STS
  3. Identify genetic tests that inform treatment decisions based on the type of non-GIST STS